Radiation Lobectomy-A Minimally Invasive Treatment Model for Liver Cancer
<dl class="AbstractPlusReport"><dt class="head">1: J Vasc Interv Radiol. 2009 Mar 26. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/corehtml...PubMedLink.gif <script language="JavaScript1.2"><!-- var Menu19328722 = [ ["UseLocalConfig", "jsmenu3Config", "", ""], ["LinkOut", "window.top.location='/sites/entrez?Cmd=ShowLinkOut&Db=pubmed&TermToSearch=1932 8722&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubm ed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubme d_RVAbstractPlus' ", "", ""] ] --></script>Links
</dt><dd class="abstract"> Radiation Lobectomy-A Minimally Invasive Treatment Model for Liver Cancer: Case Report. <!--AuthorList-->Siddiqi NH, Devlin PM. Division of Vascular and Interventional Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 South Kingshighway Boulevard, St. Louis, MO 63110. Chemotherapy-resistant colon carcinoma metastases to a patient's right hepatic lobe progressed after right lobar radioembolization with yttrium-90. The metastasis-free left lobe had adequate volume as a future liver remnant. Repeat right lobar radioembolization with supratherapeutic activity of (90)Y caused shrinking of the tumors and the right lobe with no adverse outcome. With an adequate tumor-free future liver remnant, one hepatic lobe bearing a large tumor burden may be administered supratherapeutic activity of (90)Y, risking lobar ablation for greater probability of tumor eradication. This is analogous to hepatic lobectomy. This case is presented as a proof of principle. PMID: 19328722 [PubMed - as supplied by publisher </dd></dl> |
Me thinks in English this says one can aggressively repeat spheres procedure on a lobe, risking destruction if the other lobe is healthy enough to handle liver duties.
|
All times are GMT -7. The time now is 09:38 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021